Literature DB >> 27635666

Gene expression and silencing of activin receptor type 2A (ACVR2A) in myoblast cells of chicken.

P Satheesh1, T K Bhattacharya2, P Kumar1, R N Chatterjee2, S K Dhara1, C Paswan2, R Shukla2, K Dushyanth2.   

Abstract

Activin receptor type 2A (ACVR2A) acts as receptor for myostatin (MSTN) protein involved in inhibiting satellite cell proliferation and differentiation. The importance of the ACVR2A gene during embryonic and post-hatch periods in broiler and layer chicken was studied in an in vitro cell culture system. The expression pattern of the ACVR2A gene during embryonic stages was similar in broiler and layer lines. Post-hatch expression of the ACVR2A gene varied significantly between broiler and layer lines. Five shRNA molecules were designed to knockdown expression of the ACVR2A gene in chicken myoblast cells. The silencing of the ACVR2A gene in a cell culture system varied from 60% to 82%. It is concluded that between broiler and layer lines, there were no significant changes in expression of the ACVR2A gene during embryonic stages but it varied significantly during the post-hatch period. The shRNA showed silencing of the ACVR2A gene under an in vitro cell culture system.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27635666     DOI: 10.1080/00071668.2016.1219693

Source DB:  PubMed          Journal:  Br Poult Sci        ISSN: 0007-1668            Impact factor:   2.095


  2 in total

1.  Downregulation of Activin A Receptor Type 2A Is Associated with Metastatic Potential and Poor Prognosis of Colon Cancer.

Authors:  Changhua Zhuo; Dan Hu; Jing Li; Hui Yu; Xiandong Lin; Ying Chen; Yong Zhuang; Qingguo Li; Xiongwei Zheng; Chunkang Yang
Journal:  J Cancer       Date:  2018-09-08       Impact factor: 4.207

2.  Comparative analysis of silencing expression of myostatin (MSTN) and its two receptors (ACVR2A and ACVR2B) genes affecting growth traits in knock down chicken.

Authors:  T K Bhattacharya; Renu Shukla; R N Chatterjee; S K Bhanja
Journal:  Sci Rep       Date:  2019-05-24       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.